AAAAAA
Results: 1-25/48
Authors:
WILMEN A
WALKENBACH A
FULLER P
LANKATBUTTGEREIT B
GOKE R
GOKE B
Citation: A. Wilmen et al., THE GENOMIC ORGANIZATION OF THE HUMAN GLP-1 RECEPTOR GENE, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(4), 1998, pp. 299-302
Authors:
MCGREGOR GP
GOKE R
GOKE B
Citation: Gp. Mcgregor et al., BIOLOGICAL ACTIONS OF GLUCAGON-LIKE PEPTIDE (GLP)-2 REVEALED - HOW PLURIPOTENTIAL IS THE GLUCAGON GENE, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(1), 1998, pp. 25-28
Authors:
SHEIKH SP
FELDTHUS N
ORKILD H
GOKE R
MCGREGOR GP
TURNER D
MOLLER M
STUENKEL EL
Citation: Sp. Sheikh et al., NEUROPEPTIDE Y2 RECEPTORS ON NERVE-ENDINGS FROM THE RAT NEUROHYPOPHYSIS REGULATE VASOPRESSIN AND OXYTOCIN RELEASE, Neuroscience, 82(1), 1998, pp. 107-115
Authors:
HARETER A
HOFFMANN E
BODE HP
GOKE B
GOKE R
Citation: A. Hareter et al., THE POSITIVE CHARGE OF THE IMIDAZOLE SIDE-CHAIN OF HISTIDINE(7) IS CRUCIAL FOR GLP-1 ACTION, Endocrine journal, 44(5), 1997, pp. 701-705
Authors:
HORSCH D
GOKE R
EISSELE R
MICHEL B
GOKE B
Citation: D. Horsch et al., RECIPROCAL CELLULAR-DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) IMMUNOREACTIVITY AND GLP-1 RECEPTOR MESSENGER-RNA IN PANCREATIC-ISLETS OF RAT, Pancreas, 14(3), 1997, pp. 290-294
Authors:
HUPESODMANN K
GOKE R
GOKE B
THOLE HH
ZIMMERMAN B
VOIGT K
MCGREGOR GP
Citation: K. Hupesodmann et al., ENDOPROTEOLYSIS OF GLUCAGON-LIKE PEPTIDE (GLP)-1(7-36) AMIDE BY ECTOPEPTIDASES IN RINM5F CELLS, Peptides, 18(5), 1997, pp. 625-632
Authors:
WILMEN A
VANEYLL B
GOKE B
GOKE R
Citation: A. Wilmen et al., 5 OUT OF 6 TRYPTOPHAN RESIDUES IN THE N-TERMINAL EXTRACELLULAR DOMAINOF THE RAT GLP-1 RECEPTOR ARE ESSENTIAL FOR ITS ABILITY TO BIND GLP-1, Peptides, 18(2), 1997, pp. 301-305
Authors:
GOKE B
FEHMANN HC
SCHIRRA J
HARETER A
GOKE R
Citation: B. Goke et al., GLUCAGON-LIKE PEPTIDE-1 [GLP-1] - A GUT H ORMONE ON ITS WAY FROM BENCH TO BESIDE, Zeitschrift fur Gastroenterologie, 35(4), 1997, pp. 285-294
Authors:
HARETER A
HOFFMANN E
BODE H
GOKE B
GOKE R
Citation: A. Hareter et al., ROLE OF HISTIDINE-7 IN GLP-1(7-36)AMIDE ACTION, Diabetes, 46, 1997, pp. 734-734
Authors:
TANGCHRISTENSEN M
LARSEN PJ
GOKE R
FINKJENSEN A
JESSOP DS
MOLLER M
SHEIKH SP
Citation: M. Tangchristensen et al., CENTRAL ADMINISTRATION OF GLP-1-(7-36) AMIDE INHIBITS FOOD AND WATER-INTAKE IN RATS, American journal of physiology. Regulatory, integrative and comparative physiology, 40(4), 1996, pp. 848-856
Authors:
VANEYLL B
GOKE B
WILMEN A
GOKE R
Citation: B. Vaneyll et al., EXCHANGE OF W-39 BY A WITHIN THE N-TERMINAL EXTRACELLULAR DOMAIN OF THE GLP-1 RECEPTOR RESULTS IN A LOSS OF RECEPTOR FUNCTION, Peptides, 17(4), 1996, pp. 565-570
Authors:
WILMEN A
GOKE B
GOKE R
Citation: A. Wilmen et al., THE ISOLATED N-TERMINAL EXTRACELLULAR DOMAIN OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP)-1 RECEPTOR HAS INTRINSIC BINDING-ACTIVITY, FEBS letters, 398(1), 1996, pp. 43-47
Authors:
VOLZ A
GOKE R
LANKATBUTTGEREIT B
FEHMANN HC
BODE HP
GOKE B
Citation: A. Volz et al., MOLECULAR-CLONING, FUNCTIONAL EXPRESSION, AND SIGNAL-TRANSDUCTION OF THE GIP-RECEPTOR CLONED FROM A HUMAN INSULINOMA (VOL 272, PG 23, 1995), FEBS letters, 381(3), 1996, pp. 271-271
Authors:
VANEYLL B
GOKE B
WILMEN A
GOKE R
Citation: B. Vaneyll et al., EXCHANGE OF W-39 BY A WITHIN THE N-TERMINAL EXTRACELLULAR DOMAIN OF THE GLP-I RECEPTOR RESULTS IN A LOSS OF RECEPTOR FUNCTION, Diabetes, 45, 1996, pp. 662-662
Authors:
WILMEN A
VANEYLL B
GOKE R
GOKE B
Citation: A. Wilmen et al., THE EXTRACELLULAR DOMAIN OF THE GLP-I RECEPTOR IS ESSENTIAL FOR LIGAND-BINDING, Diabetes, 45, 1996, pp. 672-672
Authors:
GOKE R
HOFFMANN E
VAHL T
BODE HP
HARETER A
GOKE B
Citation: R. Goke et al., STRUCTURE-ACTIVITY RELATIONSHIP OF GLUCAGON-LIKE PEPTIDE-I, Diabetes, 45, 1996, pp. 1276-1276
Authors:
GOKE B
STEFFEN H
GOKE R
Citation: B. Goke et al., THE SIGNAL-TRANSDUCTION OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR - FISHING BEYOND THE PROTEIN-KINASE LEVEL, Acta Physiologica Scandinavica, 157(3), 1996, pp. 321-328
Authors:
GOKE R
LARSEN PJ
MIKKELSEN JD
SHEIKH SP
Citation: R. Goke et al., DISTRIBUTION OF GLP-1 BINDING-SITES IN THE RAT-BRAIN - EVIDENCE THAT EXENDIN-4 IS A LIGAND OF BRAIN GLP-1 BINDING-SITES, European journal of neuroscience, 7(11), 1995, pp. 2294-2300
Authors:
FEHMANN HC
GOKE R
GOKE B
Citation: Hc. Fehmann et al., CELL AND MOLECULAR-BIOLOGY OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-I AND GLUCOSE-DEPENDENT INSULIN RELEASING POLYPEPTIDE, Endocrine reviews, 16(3), 1995, pp. 390-410
Authors:
GOKE R
LARSEN PJ
MIKKELSEN JD
SHEIKH SP
Citation: R. Goke et al., IDENTIFICATION OF SPECIFIC BINDING-SITES FOR GLUCAGON-LIKE PEPTIDE-1 ON THE POSTERIOR LOBE OF THE RAT PITUITARY, Neuroendocrinology, 62(2), 1995, pp. 130-134
Authors:
GOKE B
GOKE R
FEHMANN HC
ARNOLD R
Citation: B. Goke et al., INCRETIN RESEARCH ON THE DEVELOPMENT OF N EW STRATEGIES FOR DIABETES THERAPY, Der Internist, 36(4), 1995, pp. 343-349
Authors:
VOLZ A
GOKE R
LANKATBUTTGEREIT B
FEHMANN HC
BODE HP
GOKE B
Citation: A. Volz et al., MOLECULAR-CLONING, FUNCTIONAL EXPRESSION, AND SIGNAL-TRANSDUCTION OF THE GIP-RECEPTOR CLONED FROM A HUMAN INSULINOMA, FEBS letters, 373(1), 1995, pp. 23-29
Authors:
HERRMANN C
GOKE R
RICHTER G
FEHMANN HC
ARNOLD R
GOKE B
Citation: C. Herrmann et al., GLUCAGON-LIKE PEPTIDE-1 AND GLUCOSE-DEPENDENT INSULIN-RELEASING POLYPEPTIDE PLASMA-LEVELS IN RESPONSE TO NUTRIENTS, Digestion, 56(2), 1995, pp. 117-126
Authors:
KOLLIGS F
FEHMANN HC
GOKE R
GOKE B
Citation: F. Kolligs et al., REDUCTION OF THE INCRETIN EFFECT IN RATS BY THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ANTAGONIST EXENDIN(9-39) AMIDE, Diabetes, 44(1), 1995, pp. 16-19
Authors:
GOKE R
SHEIKH S
ORKILD H
GOKE B
Citation: R. Goke et al., THE 3RD-CYTOPLASMATIC DOMAIN OF THE GLP-I RECEPTOR IS CRUCIAL FOR RECEPTOR-G-PROTEIN INTERACTION, Diabetes, 44, 1995, pp. 102-102